ClinicalTrials.gg
Enrolling by invitationNCT07868705RCTUpdated Oct 9, 2026

This RCT Compares the Clinical Performance, Stability, and Patient Perception of Different Diameters Orthodontic Miniscrews in the Posterior Maxilla Buccal Side.

An interventional study of Orthodontic miniscrew, 1.3-mm diameter and 8-mm length and Orthodontic miniscrew, 1.6-mm diameter and 8-mm length in Orthodontic Miniscrew Survival and Malocclusion, sponsored by National University of Malaysia. Enrolling by invitation at 1 site in Malaysia. Open to participants aged 13 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by National University of Malaysia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2026, registered Oct 2026).
Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
13 Years to 50 Years
Sex
All
01

Study summary

Researchers will compare miniscrews with diameters of 1.3 millimeters and 1.6 millimeters. Both sizes are 8 millimeters long and will be placed between the roots of the first and second molar teeth at the back of the upper jaw. Participants will be assigned by chance to one of the two groups.

Participants will:

  • Have miniscrews of their assigned size placed as part of their treatment with braces.
  • Have the miniscrews and surrounding gums checked after placement and at monthly orthodontic appointments for six months.
  • Complete questionnaires immediately after placement and at monthly appointments for six months to report pain, chewing difficulties, food getting trapped around the miniscrews, and avoidance of smiling.
02

Conditions studied

  • Orthodontic Miniscrew Survival
  • Malocclusion

Browse trials for

03

In context

Malocclusion

469 studies on the registry are indexed under Malocclusion; 91 are open to participants now.

This study's planned enrollment of 38 is close to the median of 36 across 383 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

National University of Malaysia is the lead sponsor of 124 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Non-smoker Age 13 to 50 years old Good oral hygiene

Class II Division 1 Malocclusion patients who:

Need moderate to high anchorage cases Half-unit to full-unit class II molar relationship Quarter or half-unit class II canine relationship Overjet of more than 6mm Patients who have extraction of maxillary first premolars Patients who are willing to participate in this study.

Exclusion criteria

Exclusion Criteria:

  • Pre-existing pathology in the maxillary buccal alveolar process where OMs are to be placed.

Pre-existing chronic sinusitis Pre-existing pulpal or periodontal pathology in the maxillary posterior region. Systemic diseases which can affect maxillary and mandibular bone quality such as osteoporosis.

Patients who require orthognathic surgery

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    Orthodontic miniscrew, 1.3-mm diameter and 8-mm length

    Participants randomly assigned to Group I will receive AbsoAnchor® power-head orthodontic miniscrews (Dentos, Daegu, South Korea), measuring 1.3 mm in diameter and 8 mm in length. The miniscrews will be inserted into the interradicular area between the maxillary first and second molars as part of fixed appliance orthodontic treatment.

    Device: Orthodontic miniscrew, 1.3-mm diameter and 8-mm length

  • Active comparator
    Orthodontic miniscrew, 1.6-mm diameter and 8-mm length

    Participants randomly assigned to Group II will receive AbsoAnchor® power-head orthodontic miniscrews (Dentos, Daegu, South Korea), measuring 1.6 mm in diameter and 8 mm in length. The miniscrews will be inserted into the interradicular area between the maxillary first and second molars as part of fixed appliance orthodontic treatment.

    Device: Orthodontic miniscrew, 1.6-mm diameter and 8-mm length

Interventions

  • DeviceOrthodontic miniscrew, 1.3-mm diameter and 8-mm length

    -AbsoAnchor® power-head orthodontic miniscrews (Dentos, Daegu, South Korea), measuring 1.3 mm in diameter and 8 mm in length, will be inserted into the interradicular area between the maxillary first and second molars. The miniscrews will be used as part of fixed appliance orthodontic treatment in participants assigned to Group I.

  • DeviceOrthodontic miniscrew, 1.6-mm diameter and 8-mm length

    AbsoAnchor® power-head orthodontic miniscrews (Dentos, Daegu, South Korea), measuring 1.6 mm in diameter and 8 mm in length, will be inserted into the interradicular area between the maxillary first and second molars. The miniscrews will be used as part of fixed appliance orthodontic treatment in participants assigned to Group II.

06

What researchers measure

Primary outcomes

  1. Orthodontic miniscrew survival at 6 months

    Each miniscrew will be examined immediately after placement and at monthly orthodontic review appointments. A miniscrew that becomes loose, mobile, or fractured will be classified as a failure. Survival will be evaluated separately for the 1.3-mm and 1.6-mm diameter groups.

    Time frame: From miniscrew placement to 6 months, with assessments immediately after placement and at months 1, 2, 3, 4, 5, and 6.

Other outcomes

  1. Gingival inflammation around the miniscrew

    Gingival inflammation surrounding each orthodontic miniscrew will be assessed by visual inspection and probing using the protocol-specified gingival index. Scores range from 0 to 3: 0 indicates no inflammation; 1 indicates mild inflammation without bleeding on probing; 2 indicates moderate inflammation with bleeding on probing; and 3 indicates severe inflammation with a tendency towards spontaneous bleeding. Higher scores indicate more severe gingival inflammation.

    Time frame: Immediately after miniscrew placement and at months 1, 2, 3, 4, 5, and 6.

  2. Maxillary sinus perforation assessed using CBCT

    Maxillary sinus perforation associated with orthodontic miniscrew placement will be assessed using cone-beam computed tomography (CBCT). Perforation will be recorded as present or absent for each miniscrew. The percentage of miniscrews showing maxillary sinus perforation will be evaluated separately for the 1.3-mm and 1.6-mm diameter groups at each assessment.

    Time frame: Immediately after miniscrew placement (T0) and 6 months after placement (T6).

  3. Patient-reported questionnaire

    A modified questionnaire assessing pain, difficulty chewing, food impaction, and avoidance of smiling.

    Time frame: immediately after placement and monthly through 6 months.

07

Study locations

1 site
  • Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia
    Kuala Lumpur, 53000, Malaysia
08

References and documents

Individual participant data

Plan to share: Undecided — A decision on sharing de-identified individual participant data has not yet been made. Any future sharing would need to comply with participant consent, ethical approval, and institutional requirements.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07868705
Responsible party
Sponsor
First posted
Oct 9, 2026
Start date
Apr 15, 2026
Primary completion
Sep 30, 2026 (estimated)
Completion
Jan 31, 2028 (estimated)
Last update
Oct 9, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion